On Friday, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) opened higher 22.49% from the last session, before settling in for the closing price of $0.42. Price fluctuations for MREO have ranged from $0.20 to $3.84 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 34.82% over the past five years. Company’s average yearly earnings per share was noted 1.00% at the time writing. With a float of $137.51 million, this company’s outstanding shares have now reached $159.10 million.
Mereo Biopharma Group Plc ADR (MREO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mereo Biopharma Group Plc ADR is 13.57%, while institutional ownership is 57.39%.
Mereo Biopharma Group Plc ADR (MREO) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.01 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.01) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.64% during the next five years compared to 34.82% growth over the previous five years of trading.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Trading Performance Indicators
Check out the current performance indicators for Mereo Biopharma Group Plc ADR (MREO). In the past quarter, the stock posted a quick ratio of 8.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 159.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Mereo Biopharma Group Plc ADR (MREO)
As of the previous 9 days, the stock’s Stochastic %D was 11.51%.
During the past 100 days, Mereo Biopharma Group Plc ADR’s (MREO) raw stochastic average was set at 14.30%, which indicates a significant decrease from 14.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1331 in the past 14 days, which was higher than the 0.1119 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8363, while its 200-day Moving Average is $2.0582. Nevertheless, the first resistance level for the watch stands at $0.5439 in the near term. At $0.5773, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6443. If the price goes on to break the first support level at $0.4435, it is likely to go to the next support level at $0.3765. The third support level lies at $0.3431 if the price breaches the second support level.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Key Stats
There are currently 159,132K shares outstanding in the company with a market cap of 81.20 million. Presently, the company’s annual sales total 0 K according to its annual income of -43,250 K. Last quarter, the company’s sales amounted to 500 K and its income totaled -14,620 K.
